Search Results - "Morlà, Rosa María"

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis by Gratacós, Jordi, Pontes, Caridad, Juanola, Xavier, Sanz, Jesús, Torres, Ferran, Avendaño, Cristina, Vallano, Antoni, Calvo, Gonzalo, de Miguel, Eugenio, Sanmartí, Raimon

“…The objective was to determine if dose reduction is non-inferior to full-dose TNFi to maintain low disease activity (LDA) in patients already in remission with…”
Get full text

Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study by Corominas, Héctor, Alegre, Cayetano, Narváez, Javier, Fernández-Cid, Carlos Marras, Torrente-Segarra, Vicenç, Gómez, Manuel Rodríguez, Pan, Francisco Maceiras, Morlà, Rosa María, Martínez, Fernando José Rodríguez, Gómez-Centeno, Antoni, Ares, Laura Losada, Molina, Rocío González, González-Albo, Silvia Paredes, Dalmau-Carolà, Joan, Pérez-García, Carolina, Álvarez, Ceferino Barbazán, Ercole, Liliana, Terrancle, Maria Ángeles

“…To assess the hypothesis if tocilizumab (TCZ) is effective on disease activity, and also its effect in fatigue and other clinical and psychological…”
Get full text

Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples by Macias‐Muñoz, Laura, Frade‐Sosa, Beatriz, Iniciarte‐Mundo, Jose, Hidalgo, Susana, Morla, Rosa Maria, Gallegos, Yadira, Sanmarti, Raimon, Auge, Josep Maria

“…Background Calprotectin is a calcium‐binding protein that can be measured in serum, plasma, and feces. Increased serum and plasma calprotectin concentrations…”
Get full text